| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1109-1123.)
© 2007 American Heart Association, Inc.
Heart Disease in Latin America |
From the Cardiology Division (J.A.M.-N., B.C.M., M.V.S.), Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo; the Heart Institute (InCor), University of São Paulo, and Institute for Investigation in Immunology, Millenium InstitutesConselho Nacional de Pesquisa (E.C.-N.), São Paulo, Brazil.
Correspondence to Jose A. Marin-Neto, MD, PhD, AV Bandeirantes, 3900 Ribeirão Preto, São Paulo, Brazil 14048-900. E-mail marin_neto{at}yahoo.com
Received March 3, 2006; accepted May 26, 2006.
Background Chagas disease remains a significant public health issue and a major cause of morbidity and mortality in Latin America. Despite nearly 1 century of research, the pathogenesis of chronic Chagas cardiomyopathy is incompletely understood, the most intriguing challenge of which is the complex host-parasite interaction.
Methods and Results A systematic review of the literature found in MEDLINE, EMBASE, BIREME, LILACS, and SCIELO was performed to search for relevant references on pathogenesis and pathophysiology of Chagas disease. Evidence from studies in animal models and in anima nobile points to 4 main pathogenetic mechanisms to explain the development of chronic Chagas heart disease: autonomic nervous system derangements, microvascular disturbances, parasite-dependent myocardial aggression, and immune-mediated myocardial injury. Despite its prominent peculiarities, the role of autonomic derangements and microcirculatory disturbances is probably ancillary among causes of chronic myocardial damage. The pathogenesis of chronic Chagas heart disease is dependent on a low-grade but incessant systemic infection with documented immune-adverse reaction. Parasite persistence and immunological mechanisms are inextricably related in the myocardial aggression in the chronic phase of Chagas heart disease.
Conclusions Most clinical studies have been performed in very small number of patients. Future research should explore the clinical potential implications and therapeutic opportunities of these 2 fundamental underlying pathogenetic mechanisms.
Key Words: autonomic nervous system cardiomyopathy Chagas disease immune system inflammation microcirculation Valsalva maneuver
This article has been cited by other articles:
![]() |
S. Yacoub, A. O. Mocumbi, and M. H Yacoub Neglected tropical cardiomyopathies: I. Chagas disease Heart, February 1, 2008; 94(2): 244 - 248. [Full Text] [PDF] |
||||
![]() |
C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al. Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review JAMA, November 14, 2007; 298(18): 2171 - 2181. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |